Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy.

Author: Jae Hoon SONG ¹ ; Ki Suck JUNG ; Moon Won KANG ; Do Jin KIM ; Hyunjoo PAI ; Gee Young SUH ; Tae Sun SHIM ; Joong Hyun AHN ; Chul Min AHN ; Jun Hee WOO ; Nam Yong LEE ; Dong Gun LEE ; Mi Suk LEE ; Sang Moo LEE ; Yeong Seon LEE ; Hyukmin LEE ; Doo Ryeon CHUNG
Author Information

1. Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea. songjh@skku.edu
Publication Type:Review
Keywords: Pneumonia; Community-acquired infections; Guideline
MeSH: Adult; Communicable Diseases; Community-Acquired Infections; Humans; Joints; Korea; Pneumonia; Tuberculosis
From: Infection and Chemotherapy 2009;41(3):133-153
CountryRepublic of Korea
Language:Korean
Abstract: A successful therapy of community-acquired pneumonia requires appropriate empirical antimicrobial therapy. Etiology and antimicrobial susceptibility of major pathogens of pneumonia can differ by country. Therefore, an ideal treatment guideline of community-acquired pneumonia should be based on the studies performed in each country. We developed a treatment guideline for community-acquired pneumonia in immunocompetent adults in Korea. This guideline was developed by the joint committee of the Korean Society for Chemotherapy, the Korean Society of Infectious Diseases, and the Korean Academy of Tuberculosis and Respiratory diseases.